Skip to content
lifestyle.ukuncut.org.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Harbour Biomed
Harbour BioMed Announces NMPA Approval of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
August 18, 2026
Harbour BioMed Appoints Dr. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies
August 6, 2026
Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium
July 27, 2026
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
July 23, 2026
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results
February 9, 2026
←
Previous Page
1
2